# Diabetes Prevention Program

> **NCT00004992** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 3234 (actual)

## Conditions studied

- Diabetes Mellitus, Non-Insulin-Dependent
- Glucose Intolerance

## Interventions

- **BEHAVIORAL:** Intensive lifestyle
- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00004992
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** 2001-04
- **Final completion:** 2001-04
- **Target enrollment:** 3234 (ACTUAL)
- **Last updated:** 2018-03-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004992, "Diabetes Prevention Program". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00004992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*